Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (2)
  • 2025 (7)
  • 2024 (14)
  • 2023 (25)
  • 2022 (30)
  • 2021 (54)
  • 2020 (17)
  • 2019 (4)

Subject

  • Prescription Drugs (72)
  • Diversion Division (55)
  • Pharmaceuticals/Pharmacists/Physicians (54)
  • Drug Trafficking (49)
  • Synthetic drugs (39)
  • Seizures (Drugs/Property) (31)
  • Task Forces/Task Force Officers (27)
  • Major Law Enforcement Operation (18)
  • Outreach/Drug Prevention (17)
  • Overdose (17)
  • OCDETF/Task Force (14)
  • Fake Pills (13)
  • Arrests/Convictions - Major (12)
  • Guilty Plea (8)
  • One Pill Can Kill (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Guns/Weapons (6)
  • Press Conferences (6)
  • Take Back Day (6)
  • Fentanyl Awareness (5)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Gangs (2)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Narcoterrorism (1)

Drug Name

  • Fentanyl (2538)
  • Methamphetamine (2099)
  • Cocaine (1896)
  • Heroin (1174)
  • Marijuana (Cannabis) (338)
  • Oxycodone (279)
  • Synthetic Opioids (150)
  • Ecstasy/MDMA (51)
  • Benzodiazepines (24)
  • Morphine (21)
  • Amphetamines (18)
  • Steroids (18)
  • Ketamine (15)
  • Marijuana Concentrates (14)
  • Methadone (13)
  • Xylazine (12)
  • K2/Spice (11)
  • LSD (11)
  • Psilocybin (5)
  • Synthetic Bath Salts or Designer Cathinones (4)
  • GHB (2)
  • Barbiturates (1)
  • Peyote & Mescaline (1)
  • Opioids (120)
  • Hydromorphone (39)

Field Division

  • Washington, DC (56)
  • Miami (15)
  • Seattle (15)
  • Atlanta (14)
  • New England (10)
  • Dallas (6)
  • San Francisco (6)
  • St. Louis (6)
  • Headquarters (5)
  • Chicago (4)
  • Houston (4)
  • New York (4)
  • New Jersey (2)
  • San Diego (2)
  • Detroit (1)
  • El Paso (1)
  • Rocky Mountain (1)
Clear All Results
153 Results - Showing 71 to 80
PRESS RELEASE

Arlington Doctor Sentenced to 12 Years in Pill Mill Case

DALLAS, TX- An Arlington physician has been sentenced to 12 years in federal prison for fraud and drug crimes, announced DEA Special Agent in Charge Eduardo A. Chávez. In July 2021, a federal jury convicted physician Clinton Battle, 69, of one count of conspiracy to distribute controlled substances and one...
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

LYNCHBURG, Va. – A Madison Heights, Virginia man, and former veterinarian, pleaded guilty to a pair of drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to the adulteration of a drug held...
PRESS RELEASE

Former Virginia Veterinarian Pleads Guilty to Drug Charges

LYNCHBURG, Va. – A Madison Heights, Virginia man and former veterinarian pleaded guilty to a pair of misdemeanor drug charges related to his diversion of hydromorphone, an opioid drug also known under the trade name of “Dilaudid.” Patrick Gries, 54, pleaded guilty last week to one count of adulteration of...
PRESS RELEASE

Jacksonville Pharmacist, Pharmacy Owner Admit to Charges Related to Illegally Filling Drug Prescriptions Issued by South Georgia Doctor

BRUNSWICK, GA: A pharmacist and a pharmacy owner await sentencing after pleading guilty to charges related to a conspiracy to unlawfully dispense controlled substances. Gilbert Nelson Weise, Jr., 58, of Jacksonville, Fla., faces up to five years in prison after pleading guilty to a charge of conspiracy to dispense controlled...
PRESS RELEASE

Maryland Nurse Practitioner Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

Greenbelt, Md., – Justina Aburime, age 53, of Bowie, Maryland, pleaded guilty today to one count of conspiracy to distribute and dispense oxycodone and one count of distribution and dispensing of oxycodone. The guilty plea was announced by Jarod Forget, Special Agent in Charge of the DEA Washington Division; United...
PRESS RELEASE

Pain Clinic Doctor and Staff Member Charged with Unlawful Distribution of Opioids

TAMPA, Fla. – United States Attorney Roger B. Handberg announced the return of an indictment charging Dr. Qing McGaha (55, Tampa) with conspiracy to commit unlawful distribution of controlled substances and unlawful distribution of controlled substances for no legitimate medical purpose and outside the usual course of professional practice, as...
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
PRESS RELEASE

Post Falls Doctor Pays $110,000 for Overprescribing Opioids

COEUR D’ALENE – Dr. Eric Benson, an internist practicing medicine in Post Falls, Idaho, agreed to pay $110,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients between 2014-2021. The settlement, which was based in part on Dr. Benson’s ability to pay, also restricts the...

Pagination

  • First page «
  • Previous
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster